Natixis »

Catalyst Pharmaceutical Partners shares owned by Natixis

Quarter-by-quarter ownership of Catalyst Pharmaceutical Partners (CPRX) shares owned by Natixis from 13F filings

Historical chart of Natixis investment in Catalyst Pharmaceutical Partners

Tip: Access up to 7 years of quarterly data

All positions including Catalyst Pharmaceutical Partners held by Natixis consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Catalyst Pharmaceutical Partners by Natixis

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.7M 88k 19.70
2023-09-30 $1.3M 108k 11.69
2022-03-31 $1.9M 225k 8.29
2021-12-31 $1.6M 236k 6.77

More positions owned by Natixis

NVIDIA Corporation (NVDA)
Broadcom (AVGO)
Tesla Motors (TSLA)
Meta Platforms Cl A (META)
Spdr S&p 500 Etf Tr Tr Unit (SPY)
Microsoft Corporation (MSFT)
Alphabet Cap Stk Cl A (GOOGL)
Apple (AAPL)
Coinbase Global Com Cl A (COIN)
Strategy Cl A New (MSTR)
Energy Transfer Com Ut Ltd Ptn (ET)
JPMorgan Chase & Co. (JPM)
Amazon (AMZN)
Ishares Tr Russell 2000 Etf Call Option (IWM)
Johnson & Johnson (JNJ)

View all positions for Natixis

Top funds holding Catalyst Pharmaceutical Partners

BlackRock
Vanguard Group
State Street Corporation
Deerfield Management Company
Renaissance Technologies
Fundsmith
Morgan Stanley
Geode Capital Management
American Century Companies
Dimensional Fund Advisors
Royce & Associates
Millennium Management
Charles Schwab Investment Management
Arrowstreet Capital, Limited Partnership
Robeco Investment Management

View all funds holding Catalyst Pharmaceutical Partners